Literature DB >> 8292681

Schizophrenia, narcolepsy, and HLA-DR15, DQ6.

A B Douglass1, J E Shipley, R F Haines, R C Scholten, E Dudley, A Tapp.   

Abstract

A strong association between HLA-DR2, DQ1 and narcolepsy-cataplexy has been known since 1986. In 1990 a subdivision (HLA-DR15, DQ6) was shown to be equally associated. Narcolepsy symptoms include rapid eye movement (REM)-sleep intrusion hallucinations during the day. Some narcoleptics may be so hallucinated that they become delusional and receive a diagnosis of schizophrenia. Fifty-six inpatient schizophrenics and 56 normal controls were compared to see if there was an excess of the narcolepsy-associated antigens (NAA) among schizophrenics. Patients had frequency of the NAA 3.89 times higher than controls. After a subset was studied by night (n = 9) and day (n = 7) polysomnography, two patients were found to be true narcoleptics. Their psychosis improved with treatment for narcolepsy. When NAA(+) and NAA(-) schizophrenics were compared, the NAA(+) subgroup had significantly higher Brief Psychiatric Rating Scale (BPRS) scores and more hospitalizations. There were no effects attributable only to gender or race. We conclude that narcolepsy can simulate schizophrenia in some cases, and that even in nonnarcoleptic patients, the HLA-DR15,DQ6 antigens mark a group of severe schizophrenics that merits further study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292681     DOI: 10.1016/0006-3223(93)90066-m

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Authors:  Francesca Letizia Rocca; Elena Finotti; Fabio Pizza; Francesca Ingravallo; Michela Gatta; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

Review 2.  Sleep and mental disorders: A meta-analysis of polysomnographic research.

Authors:  Chiara Baglioni; Svetoslava Nanovska; Wolfram Regen; Kai Spiegelhalder; Bernd Feige; Christoph Nissen; Charles F Reynolds; Dieter Riemann
Journal:  Psychol Bull       Date:  2016-07-14       Impact factor: 17.737

3.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 4.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

Review 5.  The orexins/hypocretins and schizophrenia.

Authors:  Ariel Y Deutch; Michael Bubser
Journal:  Schizophr Bull       Date:  2007-08-28       Impact factor: 9.306

6.  Complex diagnostic and treatment issues in psychotic symptoms associated with narcolepsy.

Authors:  Sricharan Moturi; Anna Ivanenko
Journal:  Psychiatry (Edgmont)       Date:  2009-06

Review 7.  Hypocretin (orexin): role in normal behavior and neuropathology.

Authors:  Jerome M Siegel
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

8.  Exploring the presence of narcolepsy in patients with schizophrenia.

Authors:  Gemma Sansa; Alba Gavaldà; Carles Gaig; José Monreal; Guadalupe Ercilla; Roser Casamitjana; Gisela Ribera; Alex Iranzo; Joan Santamaria
Journal:  BMC Psychiatry       Date:  2016-06-01       Impact factor: 3.630

9.  Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study.

Authors:  Wei-Chih Chin; Feng-Yuan Liu; Yu-Shu Huang; Ing-Tsung Hsiao; Chih-Huan Wang; Ying-Chun Chen
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

10.  Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan.

Authors:  Jia-Yin Yeh; Yu-Chiau Shyu; Sheng-Yu Lee; Shin-Sheng Yuan; Chun-Ju Yang; Kang-Chung Yang; Tung-Liang Lee; Chi-Chin Sun; Liang-Jen Wang
Journal:  Front Psychiatry       Date:  2020-03-25       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.